{"id":15600,"date":"2025-04-24T13:11:46","date_gmt":"2025-04-24T13:11:46","guid":{"rendered":"https:\/\/ubc.com\/?p=15600"},"modified":"2025-05-15T21:34:00","modified_gmt":"2025-05-15T21:34:00","slug":"pv-leader-everest-group-peak-matrix-assessment-2025","status":"publish","type":"post","link":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/","title":{"rendered":"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025"},"content":{"rendered":"\n

KING OF PRUSSIA, PA, 23 April 2025<\/strong> \u2014 United BioSource LLC (UBC), a leading provider of evidence development solutions for the biopharmaceutical industry, today announced it has been named a leader in Everest Group\u2019s Pre-approval Pharmacovigilance (PV) Operations PEAK Matrix\u00ae Assessment 2025, while also earning distinction as a major contender in Everest Group\u2019s Post-approval PV Operations PEAK Matrix\u00ae Assessment 2025. These designations reflect UBC\u2019s deep understanding of the evolving safety landscape and regulations, and validates its technology suite that enables effective risk management, patient safety and regulatory compliance.<\/p>\n\n\n\n

\u201cEstablishing a technically advanced, audit-ready PV operation that prioritizes quality and compliance is essential for the success of all life science companies,\u201d remarked Geraldine Aubes, Executive Director, Global Head of UBC Pharmacovigilance. \u201cThis distinction verifies UBC\u2019s commitment to maintain patient safety and ensure high regulatory compliance throughout the drug development and commercialization process.\u201d<\/p>\n\n\n\n

The success of a PV operation is essential for all life science companies, and is shaped by evolving regulatory requirements, rising case volumes, complex safety profiles, and the need for global compliance. UBC offers a flexible, collaborative approach to delivering tailored PV programs that support regulatory obligations, ensure global safety compliance, and protect patient wellbeing. UBC\u2019s comprehensive solutions include strategic partnerships, customized programs, global regulatory expertise, end-to-end PV services, expert case processing and reporting, in-depth literature reviews, and high-quality safety writing.<\/p>\n\n\n\n

The Everest Group PEAK Matrix is a proprietary framework used to evaluate market success and technology services based on performance, experience, ability, and knowledge. Service providers are comparatively assessed on their market impact and delivery capabilities.<\/p>\n\n\n\n

In this year\u2019s assessment, Everest Group evaluated 29 leading PV operations providers featured on the PV Operations PEAK Matrix. Each provider profile presents a holistic view of service focus, solution offerings, and domain-specific investments. The analysis is based on Everest Group\u2019s annual RFI (request for information) process for calendar year 2024, along with PV provider, client reference checks, and ongoing market research.<\/p>\n\n\n\n

“Pharmacovigilance isn\u2019t just about compliance \u2014 it\u2019s about safeguarding lives with precision, expertise, and innovation. This recognition by Everest Group is a testament to our pursuit of excellence,\u201d said Natalie O\u2019Donnell\u200b, Senior Vice President and Head of Safety and Risk Management at UBC. \u201cWe\u2019re not just keeping pace with evolving safety demands \u2014 we\u2019re helping our clients stay ahead of them.\u201d<\/p>\n\n\n\n

To read about Everest Group\u2019s Pre-approval Pharmacovigilance Operations PEAK Matrix Assessment 2025, visit here<\/a>. To read about UBC\u2019s pharmacovigilance solutions, visit here<\/a>.<\/p>\n\n\n\n

\n

About UBC<\/strong><\/p>\n\n\n\n

United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit www.ubc.com<\/a>.<\/p>\n<\/div>\n\n\n\n

Media Inquiries<\/strong><\/p>\n\n\n\n

Maggie Williard
Account Executive, HDMZ
maggie.williard@hdmz.com<\/a>
(312) 506-5239<\/p>\n","protected":false},"excerpt":{"rendered":"

UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. The recognition highlights UBC\u2019s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.<\/p>\n","protected":false},"author":13,"featured_media":15603,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[197,196],"class_list":["post-15600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press","tag-pharmacovigilance","tag-pv"],"acf":[],"yoast_head":"\nUBC Named a Pharmacovigilance Leader - UBC<\/title>\n<meta name=\"description\" content=\"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025\" \/>\n<meta property=\"og:description\" content=\"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"UBC\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-24T13:11:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-15T21:34:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Ariana Garcia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ariana Garcia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\"},\"author\":{\"name\":\"Ariana Garcia\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/93746a87c469c1b2c2432395c5d35ab8\"},\"headline\":\"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025\",\"datePublished\":\"2025-04-24T13:11:46+00:00\",\"dateModified\":\"2025-05-15T21:34:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\"},\"wordCount\":514,\"commentCount\":156,\"publisher\":{\"@id\":\"https:\/\/ubc.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp\",\"keywords\":[\"pharmacovigilance\",\"pv\"],\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\",\"url\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\",\"name\":\"UBC Named a Pharmacovigilance Leader - UBC\",\"isPartOf\":{\"@id\":\"https:\/\/ubc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp\",\"datePublished\":\"2025-04-24T13:11:46+00:00\",\"dateModified\":\"2025-05-15T21:34:00+00:00\",\"description\":\"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.\",\"breadcrumb\":{\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp\",\"width\":2560,\"height\":1440,\"caption\":\"Two diverse professionals, a man and a woman, collaborate intently on a computer screen in a dimly lit office. The man points at the monitor while the woman observes.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ubc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ubc.com\/#website\",\"url\":\"https:\/\/ubc.com\/\",\"name\":\"UBC\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ubc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ubc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ubc.com\/#organization\",\"name\":\"UBC\",\"url\":\"https:\/\/ubc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"contentUrl\":\"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png\",\"width\":188,\"height\":50,\"caption\":\"UBC\"},\"image\":{\"@id\":\"https:\/\/ubc.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/93746a87c469c1b2c2432395c5d35ab8\",\"name\":\"Ariana Garcia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ubc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1eb312cf94d9de9a8e1a8e4785fe48674f613621195c95e50846593a4f7adfd9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1eb312cf94d9de9a8e1a8e4785fe48674f613621195c95e50846593a4f7adfd9?s=96&d=mm&r=g\",\"caption\":\"Ariana Garcia\"},\"url\":\"https:\/\/ubc.com\/news\/author\/ariana-garcia\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UBC Named a Pharmacovigilance Leader - UBC","description":"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/","og_locale":"en_US","og_type":"article","og_title":"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025","og_description":"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.","og_url":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/","og_site_name":"UBC","article_published_time":"2025-04-24T13:11:46+00:00","article_modified_time":"2025-05-15T21:34:00+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp","type":"image\/webp"}],"author":"Ariana Garcia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ariana Garcia","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#article","isPartOf":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/"},"author":{"name":"Ariana Garcia","@id":"https:\/\/ubc.com\/#\/schema\/person\/93746a87c469c1b2c2432395c5d35ab8"},"headline":"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025","datePublished":"2025-04-24T13:11:46+00:00","dateModified":"2025-05-15T21:34:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/"},"wordCount":514,"commentCount":156,"publisher":{"@id":"https:\/\/ubc.com\/#organization"},"image":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp","keywords":["pharmacovigilance","pv"],"articleSection":["Press"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/","url":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/","name":"UBC Named a Pharmacovigilance Leader - UBC","isPartOf":{"@id":"https:\/\/ubc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage"},"image":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp","datePublished":"2025-04-24T13:11:46+00:00","dateModified":"2025-05-15T21:34:00+00:00","description":"UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix\u00ae, and a major contender in the Post-approval category. Read more.","breadcrumb":{"@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#primaryimage","url":"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2025\/04\/EDS-1-RWE-Blog-Thumbnail-min-1-scaled.webp","width":2560,"height":1440,"caption":"Two diverse professionals, a man and a woman, collaborate intently on a computer screen in a dimly lit office. The man points at the monitor while the woman observes."},{"@type":"BreadcrumbList","@id":"https:\/\/ubc.com\/news\/pv-leader-everest-group-peak-matrix-assessment-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ubc.com\/"},{"@type":"ListItem","position":2,"name":"UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025"}]},{"@type":"WebSite","@id":"https:\/\/ubc.com\/#website","url":"https:\/\/ubc.com\/","name":"UBC","description":"","publisher":{"@id":"https:\/\/ubc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ubc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ubc.com\/#organization","name":"UBC","url":"https:\/\/ubc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/","url":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","contentUrl":"https:\/\/ubc.com\/wp-content\/uploads\/2023\/07\/Layer_1.png","width":188,"height":50,"caption":"UBC"},"image":{"@id":"https:\/\/ubc.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ubc.com\/#\/schema\/person\/93746a87c469c1b2c2432395c5d35ab8","name":"Ariana Garcia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1eb312cf94d9de9a8e1a8e4785fe48674f613621195c95e50846593a4f7adfd9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eb312cf94d9de9a8e1a8e4785fe48674f613621195c95e50846593a4f7adfd9?s=96&d=mm&r=g","caption":"Ariana Garcia"},"url":"https:\/\/ubc.com\/news\/author\/ariana-garcia\/"}]}},"_links":{"self":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/15600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/comments?post=15600"}],"version-history":[{"count":5,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/15600\/revisions"}],"predecessor-version":[{"id":15629,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/posts\/15600\/revisions\/15629"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media\/15603"}],"wp:attachment":[{"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/media?parent=15600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/categories?post=15600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ubc.com\/wp-json\/wp\/v2\/tags?post=15600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}